Origin Agritech Provides First Half Revenue Forecast and Updates Advancements in Hybrids and GMO Development

Financial Performance - Origin Agritech reported an estimated half-year revenue of RMB 85-95 million, reflecting a growth of 30-40% compared to the same period in the previous fiscal year [1]. Product and Innovation Updates - Two new hybrids have completed three years of national trials and are expected to receive approval this summer, with commercial availability anticipated in 2025 [2]. - An additional 15 new hybrids have entered the national official registration trial, indicating the company's commitment to expanding its product portfolio [2]. - Four GMO hybrids are currently undergoing national trials, aimed at enhancing crop resilience and yield [2]. - The company has submitted a new application for a GMO bt/gt trait for biosafety certification, demonstrating its dedication to regulatory standards in agricultural biotechnology [3]. - The successful performance of the new NEC hybrid has led to plans for large-scale planting in Xinjiang, which is expected to enhance agricultural productivity and sustainability in the region [3]. Leadership Insights - Dr. Gengchen Han, Chairman and CEO, emphasized the company's leadership in agricultural innovation, strong financial performance, and progress in product development, aiming to address food security and agricultural sustainability challenges [4]. Company Background - Origin Agritech Limited, founded in 1997 and headquartered in Beijing, is recognized as a leading Chinese agricultural technology company, with a robust biotechnology seed pipeline that includes products with glyphosate tolerance and pest resistance traits [5].